Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 287
Filter
1.
J Oleo Sci ; 71(1): 135-140, 2022.
Article in English | MEDLINE | ID: mdl-35013036

ABSTRACT

We investigated the effect of neutral lipids, polar lipids, and an emulsified formulation (EMF) on carotenoid bioaccessibility in an in vitro digestion assay of vegetables. These reagents enhanced carotenoid bioaccessibility. Contrary to our previous report, they also exhibited effects on lutein. Bile extracts/pancreatin concentrations also participated in the bioaccessibility. The EMF, which consisted of lower amounts of oil, had the same effect on lutein as rapeseed oil. These reagents also showed effects in the aging model, with more reduced bile extract/pancreatin concentrations, suggesting that lipids and EMF contributed to carotenoid bioaccessibility in bile/pancreatic juice secretions due to aging and disease.


Subject(s)
Carotenoids/pharmacokinetics , Digestion/physiology , Drug Compounding , Emulsions , Vegetables , Bile/physiology , Biological Availability , Emulsions/chemistry , In Vitro Techniques , Lipids , Lutein , Pancreatic Juice/physiology , Pancreatin/physiology , Rapeseed Oil
2.
Saudi J Gastroenterol ; 25(6): 335-340, 2019.
Article in English | MEDLINE | ID: mdl-31823862

ABSTRACT

Pancreatic fluid collections (PFCs) develop as a result of damage to the major or peripheral pancreatic ducts, complication due to acute or chronic pancreatitis, trauma or iatrogenic causes. PFCs include pancreatic pseudocysts (PPs) and walled-off necrosis (WON). PFCs usually resolve spontaneously and are asymptomatic, but if they persist, increase in dimension or became symptomatics, therapeutic intervention is required. Available therapeutic interventions include surgical, percutaneous, and endoscopic drainage. The endoscopic approach is nowadays considered the first line-treatment of PFCs due to various advantages when compared with surgical or percutaneous drainage: decreased morbidity, length of hospital stay, and reduced costs. In the last few years, the endoscopic ultrasound (EUS)-guided transmural drainage, initially with plastic stents, gained popularity. More recently, fully covered self-expanding lumen-apposing metal stents (LAMS) have been demonstrated to be both, safe and effective with high clinical and technical success, reducing the risk of perforation, peritoneal leakage, migration and facilitating the drainage of necrotic contents. In the last few years, several studies evaluating the safety and efficacy of LAMS and their differences with plastic stents have been performed, but literature on the removal timing of this device and associated complications is still limited. The aim of this review is to analyze studies reporting information about the retrieval timing of LAMS and the related adverse events.


Subject(s)
Device Removal/standards , Metals/adverse effects , Pancreatic Pseudocyst/pathology , Stents/adverse effects , Body Fluids/physiology , Drainage/instrumentation , Endoscopy/methods , Endosonography/methods , Female , Humans , Male , Necrosis , Outcome Assessment, Health Care , Pancreatic Juice/physiology , Pancreatic Pseudocyst/complications , Pancreatitis/complications , Pancreatitis/epidemiology , Pancreatitis/pathology , Treatment Outcome
3.
Rev. esp. enferm. dig ; 111(3): 243-245, mar. 2019. ilus, tab
Article in English | IBECS | ID: ibc-189833

ABSTRACT

Introduction: the appearance of the lumen-apposing metal stent (LAMS) has meant an authentic revolution. To date, the results are promising but it is necessary to note the technical incidents and LAMS-related complications. Case report: an EUS-transmural guided drainage using a HotAXIOS was planned for a 36-year-old man with oral intolerance due to a voluminous walled-off necrosis. The distal flange was left in the collection, but a total distal malposition occurred during the proximal flange delivery, despite correct apposition with visualization of the black mark. A rescue technique was performed inserting a second LAMS over-the-guidewire salvaging the initial failed transmural drainage. Discussion: This case is a reminder that in similar scenarios, extreme tension of the echoendoscope can cause a malfunction of the AXIOS stent delivery system, and lead to a total distal malposition. This "LAMS-in-LAMS" technique is feasible, effective, and a very helpful rescue technique in cases of dislodged LAMS


No disponible


Subject(s)
Humans , Male , Adult , Stents/adverse effects , Drainage/instrumentation , Duodenal Obstruction/surgery , Intestinal Atresia/surgery , Pancreatitis/etiology , Acute Disease , Drainage/methods , Pancreatic Juice/physiology
4.
Br J Surg ; 106(5): 616-625, 2019 04.
Article in English | MEDLINE | ID: mdl-30725479

ABSTRACT

BACKGROUND: Visceral obesity is one of the risk factors for clinically relevant pancreatic fistula after pancreatic resection. The objective of this study was to evaluate the impact of intraperitoneal lipolysis on postoperative pancreatic fistula. METHODS: The degree of intraperitoneal lipolysis was investigated by measuring the free fatty acid concentration in drain discharge in patients after pancreatic resection. An experimental pancreatic fistula model was prepared by pancreatic transection, and the impact of intraperitoneal lipolysis was evaluated by intraperitoneal administration of triolein (triglyceride) with, or without orlistat (lipase inhibitor). RESULTS: Thirty-three patients were included in the analysis. The free fatty acid concentration in drain discharge on postoperative day 1 was significantly associated with the development of a clinically relevant pancreatic fistula (P = 0·004). A higher free fatty acid concentration in drain discharge was associated with more visceral adipose tissue (P = 0·009). In the experimental model that included 98 rats, intraperitoneal lipolysis caused an increased amount of pancreatic juice leakage and multiple organ dysfunction. Intraperitoneal administration of a lipase inhibitor reduced lipolysis and prevented deterioration of the fistula. CONCLUSION: Intraperitoneal lipolysis significantly exacerbates pancreatic fistula after pancreatic resection. Inhibition of lipolysis by intraperitoneal administration of a lipase inhibitor could be a promising therapy to reduce clinically relevant postoperative pancreatic fistula. Surgical relevance Clinically, there are two types of pancreatic fistula after pancreatic resections: harmless biochemical leak and harmful clinically relevant pancreatic fistula. Visceral obesity is one of the known risk factors for clinically relevant pancreatic fistula; however, the underlying mechanisms remained to be elucidated. Patients with clinically relevant pancreatic fistula had a higher free fatty acid concentration in the drain discharge, suggesting a relationship between intraperitoneal lipolysis and pancreatic fistula. The experimental model of pancreatic fistula demonstrated that intraperitoneal lipolysis caused deterioration in pancreatic fistula, suggesting that intraperitoneal lipolysis is one of the mechanisms that drives biochemical leakage to clinically relevant pancreatic fistula. Intraperitoneal administration of a lipase inhibitor prevented lipolysis as well as pancreatic fistula deterioration in the experimental model, suggesting a future clinical application for lipase inhibitors in prevention of clinically relevant pancreatic fistula.


Subject(s)
Intra-Abdominal Fat/physiopathology , Lipolysis/physiology , Pancreatectomy/adverse effects , Pancreatic Fistula/etiology , Pancreaticoduodenectomy/adverse effects , Aged , Animals , Disease Models, Animal , Fatty Acids, Nonesterified/analysis , Female , Humans , Lipase/antagonists & inhibitors , Lipolysis/drug effects , Male , Middle Aged , Obesity, Abdominal/complications , Obesity, Abdominal/physiopathology , Pancreatic Fistula/prevention & control , Pancreatic Juice/physiology , Postoperative Complications/physiopathology , Rats, Sprague-Dawley , Risk Factors
5.
J Appl Physiol (1985) ; 125(1): 97-106, 2018 07 01.
Article in English | MEDLINE | ID: mdl-29517421

ABSTRACT

Pancreatic ductular epithelial cells comprise the majority of duct cells in pancreas, control cystic fibrosis transmembrane conductance regulator (CFTR)-dependent bicarbonate ([Formula: see text]) secretion, but are difficult to grow as a polarized monolayer. Using NIH-3T3-J2 fibroblast feeder cells and a Rho-associated kinase inhibitor, we produced well-differentiated and polarized porcine pancreatic ductular epithelial cells. Cells grown on semipermeable filters at the air-liquid interface developed typical epithelial cell morphology and stable transepithelial resistance and expressed epithelial cell markers (zona occludens-1 and ß-catenin), duct cell markers (SOX-9 and CFTR), but no acinar (amylase) or islet cell (chromogranin) markers. Polarized cells were studied in Ussing chambers bathed in Krebs-Ringer [Formula: see text] solution at 37°C gassed with 5% CO2 to measure short-circuit currents ( Isc). Ratiometric measurement of extracellular pH was performed with fluorescent SNARF-conjugated dextran at 5% CO2. Cells demonstrated a baseline Isc (12.2 ± 3.2 µA/cm2) that increased significantly in response to apical forskolin-IBMX (∆ Isc: 35.4 ± 3.8 µA/cm2, P < 0.001) or basolateral secretin (∆ Isc: 31.4 ± 2.5 µA/cm2, P < 0.001), both of which increase cellular levels of cAMP. Subsequent addition of apical GlyH-101, a CFTR inhibitor, decreased the current (∆ Isc: 20.4 ± 3.8 µA/cm2, P < 0.01). Extracellular pH and [Formula: see text] concentration increased significantly after forskolin-IBMX (pH: 7.18 ± 0.23 vs. 7.53 ± 0.19; [Formula: see text] concentration, 14.5 ± 5.9 vs. 31.8 ± 13.4 mM; P < 0.05 for both). We demonstrate the development of a polarized pancreatic ductular epithelial cell epithelium with CFTR-dependent [Formula: see text] secretion in response to secretin and cAMP. This model is highly relevant, as porcine pancreas physiology is very similar to humans and pancreatic damage in the cystic fibrosis pig model recapitulates that of humans. NEW & NOTEWORTHY Pancreas ductular epithelial cells control cystic fibrosis transmembrane conductance regulator (CFTR)-dependent bicarbonate secretion. Their function is critical because when CFTR is deficient in cystic fibrosis bicarbonate secretion is lost and the pancreas is damaged. Mechanisms that control pancreatic bicarbonate secretion are incompletely understood. We generated well-differentiated and polarized porcine pancreatic ductular epithelial cells and demonstrated feasibility of bicarbonate secretion. This novel method will advance our understanding of pancreas physiology and mechanisms of bicarbonate secretion.


Subject(s)
Epithelium/physiology , Pancreatic Ducts/physiology , Animals , Bicarbonates/metabolism , Cell Line , Colforsin/metabolism , Cystic Fibrosis/metabolism , Cystic Fibrosis/physiopathology , Cystic Fibrosis Transmembrane Conductance Regulator/metabolism , Epithelial Cells/metabolism , Epithelial Cells/physiology , Epithelium/metabolism , Humans , Mice , NIH 3T3 Cells , Pancreatic Ducts/metabolism , Pancreatic Juice/metabolism , Pancreatic Juice/physiology , Signal Transduction/physiology , Swine
6.
Surg Innov ; 24(3): 214-222, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28492352

ABSTRACT

BACKGROUND: Tissue-bound fibrin sealants are used in a wide array of surgical procedures. The microenvironmental interaction between sealant and application site is often poorly evaluated due to a lack of suitable experimental models. METHODS: A physiological incubation biosimulator (PIBS) was developed to test biological sealants in an ex vivo setup under physiological conditions comparable to the microenvironment at application site (temperature, humidity, pressure). PIBS was validated by a study on the effectiveness of TachoSil for leak closure at pancreatic resection sites. Defined defects in a thoracic membrane of porcine origin were sealed by TachoSil. Integrity of the sealing was tested in the presence of active pancreatic fluid over 60 minutes. Heat-inactivated pancreatic fluid and electrolyte solution served as controls. The time to leakage was recorded and experimental groups were analyzed by Kaplan-Meier analysis. RESULTS: PIBS produced reliable results. TachoSil lead to a leakage rate of 96% after incubation with active pancreatic fluid (p = 34), which was significantly higher compared with heat-inactivated pancreatic fluid (p = 34, 52%) or electrolyte solution (p = 20, 19%). CONCLUSION: PIBS is an effective tool to evaluate microenvironmental effects on the adhesive strength of biomaterials. Tissue sealing effect of TachoSil is diminished in a "pancreatic" microenvironment rich with pancreatic enzymes. Our results might therefore explain the reason of the findings of randomized controlled trials recently published on this subject.


Subject(s)
Biomedical Research , Models, Biological , Tissue Adhesives , Animals , Biomechanical Phenomena , Biomedical Research/instrumentation , Biomedical Research/methods , Diaphragm/surgery , Drug Combinations , Equipment Design , Fibrin Tissue Adhesive , Fibrinogen , Humans , Pancreas/surgery , Pancreatic Fistula/surgery , Pancreatic Juice/physiology , Swine , Thrombin
7.
Surg Today ; 44(2): 252-9, 2014 Feb.
Article in English | MEDLINE | ID: mdl-23494105

ABSTRACT

PURPOSES: External drainage of pancreatic juice using a pancreatic duct stent following pancreatoduodenectomy is widely performed. We hypothesized that the replacement of externally drained pancreatic juice would help to prevent postoperative complications, including pancreatic fistulas. METHODS: Sixty-four patients who underwent pancreatoduodenectomy between 2006 and 2008 were randomly assigned to either a pancreatic juice non-replacement (NR) or replacement (R) group. Eighteen patients were excluded from the analysis because they had unresectable tumors (n = 4), low pancreatic juice output (<100 ml) (n = 11) or for other reasons (n = 3). A total of 46 patients (NR = 24, R = 22) were included in the final analysis. The volume and amylase levels of externally drained pancreatic juice were analyzed on postoperative days 7 and 14. The incidence of postoperative complications, including pancreatic fistulas and delayed gastric emptying, was also assessed. RESULTS: The total amylase secretion from the pancreatic tube on postoperative day 7 was significantly higher in the NR group compared with the R group (P = 0.044). The incidence of pancreatic fistulas (>Grade B) was also significantly higher in the NR group (33.3 vs. 9.1 %, P = 0.046). CONCLUSIONS: In cases for whom external pancreatic juice drainage from a stent is applied following pancreaticojejunostomy, enteral replacement of externally drained pancreatic juice may reduce the incidence of postoperative pancreatic fistula formation.


Subject(s)
Enteral Nutrition , Pancreatic Fistula/prevention & control , Pancreatic Juice , Pancreaticoduodenectomy , Postoperative Complications/prevention & control , Adult , Aged , Amylases/analysis , Drainage/methods , Female , Humans , Male , Middle Aged , Pancreatic Ducts , Pancreatic Juice/enzymology , Pancreatic Juice/metabolism , Pancreatic Juice/physiology , Stents , Time Factors
8.
Zentralbl Chir ; 138(4): 471-9, 2013 Aug.
Article in German | MEDLINE | ID: mdl-23575520

ABSTRACT

BACKGROUND: Due to uncontrolled activation of digestive enzymes produced within the pancreas, acute pancreatitis is a disease with a great potential for complications and variable course. Since the pathophysiological steps of human pancreatitis can only be inadequately investigated, various animal models were established to study the course of disease. The model of supramaximal caerulein stimulation allows to gain insights into intracellular events of the early phase of acute pancreatitis. Usually, overnight fasted animals are used for the model of acute pancreatitis to achieve a maximum zymogen granula accumulation and a standardised initial situation due to diminished secretion of CCK. Furthermore, the role of the nutritional state for pathogenesis and course of acute pancreatitis is controversially discussed. The aim of the study was to investigate the impact of the nutritional status on pancreatic injury in experimental acute pancreatitis. METHODS: Using standardised supramaximal caerulein stimulation (dose: 50 µg/kg; time intervals, 1/h; max. 7×), acute oedematous interstitial pancreatitis in fasted and non-fasted mice was induced. Pancreatic injury was locally characterised by pancreatic oedema, histopathological alterations and the release of pancreatic enzyme to the serum while systemic alterations were objectified by IL-6, CRP und pulmonal MPO. RESULTS: 1) Increased pancreatic serum enzyme levels after induction of acute pancreatitis in non-fasted animals do not reflect a greater affection of the pancreas since amylase and lipase in serum and pancreatic tissue correlate proportionally. The induction of acute pancreatitis provoked release of 1.3 % and 0.7 % of amylase and lipase, respectively, independently of nutritional status. 2) Neither local nor systemic parameters of pancreatic injury were significantly altered by the nutritional regimen. Pathohistologic investigations revealed increase of zymogen granula portion and cell size in non-fasted mice but no further differences compared with fasted animals. 3) During a 16-hour recovery period (no further caerulein injection), local and systemic parameters normalised. DISCUSSION: In the relatively mild model of pancreatitis induced by hormonal hyperstimulation, there was no greater pancreatic injury despite higher intrapancreatic enzyme accumulation in non-fasted animals indicating a steady state between potentially damaging and protective factors and mechanisms.


Subject(s)
Disease Models, Animal , Nutritional Status , Pancreatitis, Acute Necrotizing/physiopathology , Animals , Cholecystokinin/physiology , Enzyme Precursors/physiology , Female , Humans , Male , Mice , Mice, Inbred Strains , Pancreas/pathology , Pancreas/physiopathology , Pancreatic Juice/physiology , Pancreatitis, Acute Necrotizing/complications , Pancreatitis, Acute Necrotizing/pathology , Secretory Vesicles/pathology , Secretory Vesicles/physiology
9.
Pancreas ; 41(8): 1292-8, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22647734

ABSTRACT

OBJECTIVES: Mutation in the Pkhd1 gene that encodes a ciliary protein, fibrocystin, causes multiple cysts in the kidneys and liver in the polycystic kidney (PCK) rat, a model for human autosomal recessive PCK disease. To clarify the role of primary cilia in the pancreatic duct, we examined the structure and function of the exocrine pancreas of PCK rats. METHODS: Pancreatic juice and bile were collected from anesthetized rats. Pancreatic ductal structure was analyzed by microdissection and immunohist0chemistry. RESULTS: Histologically pancreatic acini were apparently normal, and no cysts were detected in the pancreas. Larger pancreatic ducts were irregularly dilated with enhanced expression of AQP1 in epithelial cells. The pancreatic duct of PCK rats exhibited significantly (P < 0.05) higher distensibility than that of wild-type (WT) rat at a physiological luminal pressure (3 cm H2O). Pancreatic fluid secretion stimulated with a physiological dose of secretin (0.03 nmol/kg per hour) in PCK rats was significantly smaller than that in WT, but the differences were not significant at higher doses. The amylase responses to carbamylcholine were not different between PCK and WT rats. CONCLUSIONS: These findings suggest that fibrocystin/primary cilia-dependent mechanisms may play a role in the regulation of pancreatic ductal structure and fluid secretion.


Subject(s)
Pancreas, Exocrine/physiopathology , Polycystic Kidney Diseases/pathology , Amylases/metabolism , Animals , Aquaporin 1/biosynthesis , Bile/drug effects , Carbachol/administration & dosage , Cholinergic Agonists/administration & dosage , Disease Models, Animal , Humans , Liver/drug effects , Liver/pathology , Male , Mutation , Pancreas, Exocrine/drug effects , Pancreas, Exocrine/pathology , Pancreatic Ducts/pathology , Pancreatic Ducts/physiopathology , Pancreatic Juice/drug effects , Pancreatic Juice/physiology , Polycystic Kidney Diseases/genetics , Polycystic Kidney Diseases/metabolism , Rats , Rats, Sprague-Dawley , Receptors, Cell Surface/genetics , Secretin/administration & dosage
10.
Pancreas ; 41(7): 1073-9, 2012 Oct.
Article in English | MEDLINE | ID: mdl-22481285

ABSTRACT

OBJECTIVES: (1) To quantitate volume production during secretin stimulation testing in patients suspected of having chronic pancreatitis (CP); (2) to compare volume production to clinical criteria for the diagnosis of CP. METHODS: A total of 224 patients referred for suspected CP were reviewed retrospectively for clinical information supporting the diagnosis of CP. The patients were divided into 2 groups: those with peak bicarbonate (PB) of less than 80 mEq/L and those with PB of 80 mEq/L or greater (ie, CP and no CP). For a separate comparison, the patients were also placed into similar 2 groups based on clinical criteria. The volume, total bicarbonate output, volume per kilogram, and PB of pancreatic juice after secretin stimulation in patients thought to have CP were compared to those thought not to have CP. RESULTS: Volume was lower in the patients with PB of less than 80 mEq/L (206 ± 114 and 269 ± 106 mL) and lower in patients who met clinical criteria for CP (203 ± 109 and 271 ± 108 mL), P < 0.001 for both, but there was significant overlap (volume alone did not accurately discriminate CP from no CP). CONCLUSIONS: During secretin stimulation testing, bicarbonate parameters likely are better predictors of CP than volume parameters. Changes in the production of the volume of pancreatic juice during secretin stimulation likely reflect relatively late changes in pancreatic function.


Subject(s)
Pancreatic Juice/physiology , Pancreatitis, Chronic/diagnosis , Secretin , Adult , Bicarbonates/analysis , Female , Humans , Male , Middle Aged , Pancreatic Juice/chemistry , Pancreatitis, Chronic/physiopathology , ROC Curve , Retrospective Studies , Sensitivity and Specificity
11.
Br J Surg ; 98(9): 1319-26, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21725969

ABSTRACT

BACKGROUND: The aetiology of choledochal malformation is not known. Babbitt's hypothesis remains a popular concept, and assumes that activated pancreatic juice refluxes through the common pancreatobiliary channel causing mural damage and subsequent biliary dilatation. This hypothesis was tested clinically by evaluating the relationship between epithelial histology, choledochal pressure and degree of pancreatic reflux. METHODS: Children with choledochal malformation (cystic, type 1c; fusiform, type 1f; both intrahepatic and extrahepatic dilatation, type 4) operated on between January 1999 and October 2009 were identified. Where practical, choledochal pressure was measured on entry to the abdominal cavity, by puncture of the common bile duct, and bile was sampled for amylase content. Archival bile duct sections were scored using a semiquantitative epithelial lining/mural score (ELMS). RESULTS: A total of 90 children with choledochal malformations were operated on during the study interval. Histology was available for 73 children (median age 2·9 (interquartile range 1·3-7·9) years), 29 with type 1c, 31 with type 1f and 13 with type 4 malformations. There was a significant stepwise increase in pressure with choledochal morphology (median pressure 13, 17 and 20 mmHg for types 1f, 1c and 4 respectively; P = 0·037). There was an inverse relationship between choledochal pressure and bile amylase activity (r(s) = - 0·45, P < 0·001). High ELMS values were associated with higher choledochal pressure (P = 0·057) and low bile amylase activity (P = 0·002). CONCLUSION: High choledochal pressure (not bile amylase) was associated with more severe histopathological changes and choledochal morphology. These findings suggest that distal bile duct obstruction (and therefore high intraluminal pressure) contributes more to the key features of choledochal malformation than does pancreatic reflux.


Subject(s)
Common Bile Duct Diseases/etiology , Common Bile Duct/abnormalities , Pancreatic Juice/physiology , Amylases/metabolism , Bile/enzymology , Bilirubin/metabolism , Child , Child, Preschool , Common Bile Duct/surgery , Common Bile Duct Diseases/pathology , Common Bile Duct Diseases/surgery , Dilatation, Pathologic/etiology , Dilatation, Pathologic/pathology , Humans , Infant , Liver/metabolism , Pressure , gamma-Glutamyltransferase/metabolism
12.
Surgery ; 148(5): 1012-9, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20417947

ABSTRACT

BACKGROUND: The aim of the present study was to investigate the effects of diversion of biliary and pancreatic juices on upper gut motility and hormone secretion. METHODS: We used dogs equipped with strain gauge force transducers to measure upper gut motility. Dogs were divided into 5 groups: control, sham operation, biliary diversion (BD), pancreatic juice diversion (PJD), and biliopancreatic juice diversion (BPD). Postprandial plasma concentrations of insulin, gastric inhibitory polypeptide (GIP), and peptide YY (PYY) were also measured. RESULTS: Occurrence and migration velocity of the migrating motor complex in the jejunum in the interdigestive state were decreased in the BD and BPD groups compared with the other 3 groups (P < .05). In the BD and BPD groups, areas of postprandial contractile curves in the upper gut were decreased, and the duration of the postprandial contractions in the proximal jejunum, which a previous study showed to correlate with gastric emptying, were less compared with the other 3 groups (P < .05). Plasma insulin levels did not differ among the 5 groups. Plasma concentrations of GIP suppressed in the PJD and BPD groups (P < .05), whereas plasma PYY level was increased in the BD group (P < .05). CONCLUSION: Bile diversion seems to inhibit interdigestive and postprandial upper gut contractions in association with an increase of plasma PYY. Pancreatic juice was considered to play a role in the secretion of GIP.


Subject(s)
Bile/physiology , Gastrointestinal Hormones/metabolism , Gastrointestinal Motility , Ileum/physiology , Pancreatic Juice/physiology , Animals , Blood Glucose/analysis , Dogs , Gastric Inhibitory Polypeptide/metabolism , Insulin/metabolism , Insulin Secretion , Peptide YY/metabolism
13.
Langenbecks Arch Surg ; 394(2): 209-13, 2009 Mar.
Article in English | MEDLINE | ID: mdl-18712411

ABSTRACT

CLINICAL CONDITIONS AND DIAGNOSIS: Congenital dilatation of the common bile duct is a disease in which the extrahepatic bile duct, or both the extra and intrahepatic bile ducts, is dilated in various ways. Pancreaticobiliary maljunction is a disease in which the pancreatic duct meets the bile duct outside of the duodenal wall beyond the sphincter Oddi. Recently, these diseases have been thought to be closely related to each other but to be different malformations. Biliary tract carcinoma, especially bile duct carcinoma, is found in about 30% of patients with congenital dilatation of the bile duct. The concomitance of bile and pancreatic juice and their stasis in the biliary tract induce cellular proliferation and reproduction and stimulate genetic alterations in biliary epithelium, which may play an important role in carcinogenesis of the bile duct. THERAPEUTIC STRATEGIES: Endoscopic retrograde cholangiopancreatography is useful for examining pancreaticobiliary maljunction. The operation is dilated bile duct resection and hepaticojejunostomy, which ensure that pancreatic juice and bile do not mix in the bile duct. Gallbladder carcinoma develops in more than 90% of pancreaticobiliary maljunction without bile duct dilatation.


Subject(s)
Common Bile Duct/abnormalities , Common Bile Duct/pathology , Pancreatic Ducts/abnormalities , Sphincter of Oddi/abnormalities , Sphincter of Oddi/pathology , Bile/physiology , Bile Duct Neoplasms/congenital , Bile Duct Neoplasms/pathology , Bile Duct Neoplasms/surgery , Cell Transformation, Neoplastic/pathology , Cholangiocarcinoma/congenital , Cholangiocarcinoma/pathology , Cholangiocarcinoma/surgery , Cholangiopancreatography, Endoscopic Retrograde , Cholangiopancreatography, Magnetic Resonance , Common Bile Duct/surgery , Dilatation, Pathologic/genetics , Dilatation, Pathologic/surgery , Hepatic Duct, Common/pathology , Hepatic Duct, Common/surgery , Humans , Jejunostomy , Magnetic Resonance Imaging , Pancreatic Ducts/pathology , Pancreatic Ducts/surgery , Pancreatic Juice/physiology , Sphincter of Oddi/surgery
15.
J Hepatobiliary Pancreat Surg ; 15(2): 169-77, 2008.
Article in English | MEDLINE | ID: mdl-18392710

ABSTRACT

BACKGROUND/PURPOSE: Intraductal papillary-mucinous neoplasms (IPMNs) of the pancreas have a favorable prognosis. However, invasive ductal carcinomas of the pancreas show a rapid progression. The aim of this study was to investigate gene mutations in pure pancreatic juice from IPMN patients and to define these genetic mutations in relation to the histopathological and clinical features of IPMNs. METHODS: Twenty-two patients with IPMN, 21 patients with ductal carcinoma, and 20 patients with normal pancreas or chronic pancreatitis were recruited for this study. We measured the main pancreatic duct's largest diameter and the maximum size of a dilated branch was assessed by ultrasonography or endoscopic ultrasonography. Pure pancreatic juice was collected and was investigated for K-ras, p16, and p53 mutations. RESULTS: Mutant K-ras gene was detected in 13 of the 22 patients (59.1%) with IPMNs. Different kinds of mutations were detected in the same patient in 4 cases. In the 13 patients with mutant K-ras gene, the diameter of the most dilated part of the main pancreatic duct was 2-8 mm (average, 4.5 mm) and in 7 patients with wild-type K-ras gene, the diameter was 2-5 mm (average, 2.7 mm). There was a significant difference in the diameter of the main pancreatic duct between patients with and without the mutant K-ras gene (P = 0.0323). CONCLUSIONS: The incidence of K-ras mutation may be associated with the hypersecretion of mucin.


Subject(s)
Adenocarcinoma, Mucinous/genetics , Adenocarcinoma, Papillary/genetics , Genes, ras/genetics , Mucins/metabolism , Pancreatic Juice/chemistry , Aged , Carcinoma, Pancreatic Ductal/genetics , Female , Humans , Male , Middle Aged , Mutation , Pancreatic Juice/physiology
16.
Pancreas ; 36(4): 329-36, 2008 May.
Article in English | MEDLINE | ID: mdl-18437077

ABSTRACT

Pancreatic cancer is a devastating disease, with a mortality rate almost identical with its incidence. Late diagnosis and limited therapeutic options make early detection of pancreatic cancer a pressing clinical problem. In this context, the investigation of the pancreatic cancer proteome has recently gained considerable attention because profiles of proteins may be able to more accurately identify disease states, such as cancer. Recent pancreatic cancer proteome studies may be categorized into basic studies cataloguing the pancreatic proteome, studies investigating differential protein expression patterns, and studies searching for proteome-based biomarkers for early cancer detection and differentiation. Although these studies clearly demonstrate that a range of biological samples are suitable for proteomic analyses, comparison of different studies is problematic due to the diversity of methodologies, sample sources, and characterization of patient populations. Reproducibility between studies has rarely been investigated, and no investigation has compared the different methods of proteomic research. The results of this review have shown that more stringent requirements concerning the design and the analysis of future studies should be implemented. These include an adequate patient number, obligatory histological examination of tissues, appropriate control groups, identification of proteins and peaks, validation of differential expression using independent cohorts and/or a second methodology, and, finally, demonstration of result reproducibility. This will hopefully lead to the discovery of prognostic and predictive biomarkers that help to improve prognosis of pancreatic cancer patients.


Subject(s)
Pancreatic Neoplasms/genetics , Proteomics , Humans , Neoplasm Proteins/genetics , Pancreatic Juice/physiology , Pancreatic Neoplasms/epidemiology , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology
17.
JOP ; 9(1): 37-45, 2008 Jan 08.
Article in English | MEDLINE | ID: mdl-18182742

ABSTRACT

CONTEXT: Mass-forming pancreatitis can be divided into two distinct types: alcoholic and autoimmune. There have been some cases of an ambiguous diagnosis although care was taken to differentiate between alcoholic mass-forming pancreatitis, focal type autoimmune pancreatitis and pancreatic cancer. CASE REPORT: We report a case of pancreatic cancer mimicking alcoholic or autoimmune pancreatitis with the formation of a mass in a 32-year-old man with a history of heavy drinking. Although both serum immunoglobulin G and immunoglobulin G4 levels were normal, many serum auto-antibodies, including the antinuclear antibody, were detected. After he stopped drinking, abdominal computed tomography showed a pancreatic head mass 28 mm in diameter with little and weak enhancement in the early and delayed phases, respectively. Endoscopic retrograde cholangiopancreatography showed an obstruction of the main pancreatic duct in the pancreatic head and marked stenosis of the lower common bile duct. Although a percutaneous ultrasound-guided pancreatic biopsy demonstrated no evidence of autoimmune pancreatitis, he was treated with prednisolone to test the efficacy of steroid therapy. However, the pancreatic mass became enlarged after steroid therapy, and he underwent surgery during which the mass was found to be pancreatic cancer. Although the patient was treated with gemcitabine, he died 5 months after surgery. We retrospectively assessed DNA hypermethylation in the patient's pure pancreatic juice obtained on admission. We observed hypermethylation of the cancer-specific gene tissue factor pathway inhibitor 2 (TFPI2). CONCLUSION: This finding suggests that if the DNA hypermethylation of pure pancreatic juice had been assayed before steroid therapy, it would have supported the diagnosis of pancreatic cancer, and steroid therapy could have been avoided.


Subject(s)
Adenocarcinoma/diagnosis , Autoimmune Diseases/diagnosis , DNA Methylation , Pancreatic Juice/physiology , Pancreatic Neoplasms/diagnosis , Pancreatitis, Alcoholic/diagnosis , Adenocarcinoma/genetics , Adenocarcinoma/surgery , Adult , Biopsy , Cholangiopancreatography, Endoscopic Retrograde , Diagnosis, Differential , Fatal Outcome , Glycoproteins/genetics , Humans , Male , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/surgery , Ultrasonography
18.
Cancer Biol Ther ; 7(3): 353-360, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18075308

ABSTRACT

KRAS2 gene mutations are found in 75-90% of infiltrating pancreatic ductal adenocarcinomas but can also be present with other nonneoplastic pancreatic diseases. We recently developed a novel sensitive assay for point mutation detection, called "LigAmp", which can detect one mutant molecule in the presence of 10,000 wild-type molecules and can quantify mutant DNA over a wide dynamic range. We analyzed KRAS2 mutations in surgically-collected pancreatic duct juice samples from patients with pancreatic adenocarcinoma (n = 27) and chronic pancreatitis(n = 9). DNA sequencing demonstrated that 17 of the 27 pancreatic cancers harbored KRAS2 mutations at codon 12, including G12D (GGT-->GAT), G12V (GTT), and G12R (CGT). We determined the relative amounts of each KRAS2 mutant by simultaneously quantifying wild-type and mutant KRAS2 DNA. For all pancreatic adenocarcinoma patients, the dominant KRAS2 mutation detected in the pancreatic juice corresponded to that found in the primary cancer. Mutation levels were substantially higher in patients with pancreatic cancer (0.05 to 82% of total KRAS2 molecules) compared to those with chronic pancreatitis (0 to 0.7%). Among patients with mutant KRAS2 positive cancers, all but one (94%) had mutant KRAS2 DNA concentrations of more than 0.5% in their pancreatic juice samples, whereas only 1 of 9(11%) pancreatic juice samples from patients with chronic pancreatitis had more than 0.5% mutant KRAS2 DNA, corresponding to a sensitivity of 94% and a specificity of 89%. LigAmp quantification of mutant KRAS2 in pancreatic juice differentiates pancreatic adenocarcinoma from chronic pancreatitis, and may be a useful early detection tool for pancreatic cancer.


Subject(s)
Adenocarcinoma/genetics , Mutation , Pancreatic Ducts/pathology , Pancreatic Juice/physiology , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/genetics , Point Mutation , Proto-Oncogene Proteins/genetics , ras Proteins/genetics , Adenocarcinoma/diagnosis , Adenocarcinoma/etiology , Chronic Disease , Diagnosis, Differential , Humans , Pancreatic Neoplasms/etiology , Pancreatitis/complications , Polymerase Chain Reaction , Proto-Oncogene Proteins p21(ras)
19.
Curr Drug Abuse Rev ; 1(2): 197-202, 2008 Jun.
Article in English | MEDLINE | ID: mdl-19630718

ABSTRACT

Chronic pancreatitis is a progressive inflammatory condition characterized by repeated attacks of abdominal pain, and the destruction and fibrosis of the pancreatic parenchyma which causes to reduced exocrine and endocrine functions. Alcohol is the most common cause of chronic pancreatitis. Although abstinence is usually considered a prerequisite for successful treatment of alcoholic chronic pancreatitis, we often encounter patients who have repeated attacks from the compensated stage through the transitional stage. In alcoholic chronic pancreatitis, continued alcohol consumption causes changes in the digestive hormones and vagal nerve function that induce the pancreatic acinar cells to oversecrete protein, increasing the protein concentration and viscosity of the pancreatic juice. This induces protein sedimentation from the pancreatic juice and formation of protein plugs within the pancreatic duct, triggering repeated attacks of acute pancreatitis. The treatment of alcoholic chronic pancreatitis includes alleviation of symptoms, particularly abdominal pain, elimination of trigger factors, prevention of recurrence and disease progression, adjuvant therapies for pancreatic exocrine and endocrine failure. Recently, the main constituent proteins in these protein plugs have been identified, enabling trials of several therapies, such as the administration of secretin formulations and endoscopic removal. Bromhexine hydrochloride, a bronchial mucolytic, has an affinity for the pancreatic acinar cells, inducing them to secrete pancreatic juice of low viscosity. In this review, we summarize the most recent thoughts about alcoholic chronic pancreatitis, and the new treatments, and in particular, we present our findings concerning the efficacy of bromhexine hydrochloride in the treatment of this disease.


Subject(s)
Pancreatitis, Alcoholic/therapy , Alcoholism/physiopathology , Alcoholism/rehabilitation , Bromhexine/administration & dosage , Combined Modality Therapy , Disease Progression , Endoscopy , Exocrine Pancreatic Insufficiency/physiopathology , Exocrine Pancreatic Insufficiency/therapy , Gastrointestinal Hormones/physiology , Humans , Life Style , Pancreatic Juice/physiology , Pancreatitis, Alcoholic/physiopathology , Recurrence , Secretin/administration & dosage , Vagus Nerve/physiopathology , Viscosity
20.
Intern Med ; 46(22): 1853-6, 2007.
Article in English | MEDLINE | ID: mdl-18025767

ABSTRACT

The papilla of Vater emptying into the duodenal bulb site is extremely rare and considered an aberrant condition. We report here a case with recurrent duodenal ulcer bleeding associated with this anomaly. A 42-year-old man was admitted to St. Mary Hospital because of tarry stool for three days. Despite no documented etiology to explain recurrent ulceration, the patient had about ten episodes of ulcer bleeding since 1995. On duodenoscopy, 1.0 x 0.6 cm sized active stage duodenal ulcer with oozing was observed at the posterior wall side below the pylorus. The papilla of Vater was bulging just below the pylorus. Bile juice was excreted from its opening. Pancreatic duct and common bile duct, which drained into the bulb site, were observed on ERCP. In this report, we show that recurrent duodenal ulcer can be associated with the papilla of Vater just below the pylorus.


Subject(s)
Duodenal Ulcer/etiology , Duodenum/abnormalities , 2-Pyridinylmethylsulfinylbenzimidazoles/therapeutic use , Adult , Anti-Ulcer Agents/therapeutic use , Bile/drug effects , Bile/physiology , Bile Ducts/abnormalities , Duodenal Ulcer/complications , Duodenal Ulcer/drug therapy , Esters , Gabexate/analogs & derivatives , Gabexate/therapeutic use , Gastrointestinal Hemorrhage/etiology , Guanidines , Humans , Male , Pancreatic Ducts/abnormalities , Pancreatic Juice/drug effects , Pancreatic Juice/physiology , Protease Inhibitors/therapeutic use , Rabeprazole
SELECTION OF CITATIONS
SEARCH DETAIL
...